Compare Panacea Biotech with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs FDC LTD. - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH FDC LTD. PANACEA BIOTECH/
FDC LTD.
 
P/E (TTM) x 11.6 16.1 72.1% View Chart
P/BV x 2.8 2.2 128.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   FDC LTD.
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-18
FDC LTD.
Mar-18
PANACEA BIOTECH/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs364319 114.1%   
Low Rs129164 78.7%   
Sales per share (Unadj.) Rs96.861.6 157.0%  
Earnings per share (Unadj.) Rs-12.49.9 -124.7%  
Cash flow per share (Unadj.) Rs-2.912.0 -23.8%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs50.473.2 68.9%  
Shares outstanding (eoy) m61.25174.40 35.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.53.9 65.0%   
Avg P/E ratio x-19.924.3 -81.9%  
P/CF ratio (eoy) x-86.420.2 -428.2%  
Price / Book Value ratio x4.93.3 148.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,10142,118 35.9%   
No. of employees `0002.55.5 44.6%   
Total wages/salary Rs m1,5162,167 70.0%   
Avg. sales/employee Rs Th2,401.91,943.7 123.6%   
Avg. wages/employee Rs Th614.2391.7 156.8%   
Avg. net profit/employee Rs Th-307.9313.7 -98.2%   
INCOME DATA
Net Sales Rs m5,92810,751 55.1%  
Other income Rs m82510 16.1%   
Total revenues Rs m6,01011,260 53.4%   
Gross profit Rs m8452,267 37.3%  
Depreciation Rs m585351 166.6%   
Interest Rs m1,00614 7,184.3%   
Profit before tax Rs m-6642,411 -27.5%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m99671 14.7%   
Profit after tax Rs m-7601,735 -43.8%  
Gross profit margin %14.321.1 67.6%  
Effective tax rate %-14.927.8 -53.4%   
Net profit margin %-12.816.1 -79.4%  
BALANCE SHEET DATA
Current assets Rs m5,6037,213 77.7%   
Current liabilities Rs m6,9102,104 328.5%   
Net working cap to sales %-22.047.5 -46.4%  
Current ratio x0.83.4 23.7%  
Inventory Days Days20654 377.7%  
Debtors Days Days8428 302.1%  
Net fixed assets Rs m9,9416,865 144.8%   
Share capital Rs m61175 35.0%   
"Free" reserves Rs m3,02612,586 24.0%   
Net worth Rs m3,08712,761 24.2%   
Long term debt Rs m5,7076 95,118.3%   
Total assets Rs m16,07615,041 106.9%  
Interest coverage x0.3173.2 0.2%   
Debt to equity ratio x1.80 393,214.7%  
Sales to assets ratio x0.40.7 51.6%   
Return on assets %1.511.6 13.1%  
Return on equity %-24.613.6 -181.1%  
Return on capital %3.919.0 20.7%  
Exports to sales %24.012.3 194.7%   
Imports to sales %17.50-   
Exports (fob) Rs m1,4241,327 107.3%   
Imports (cif) Rs m1,040NA-   
Fx inflow Rs m1,6001,889 84.7%   
Fx outflow Rs m1,1310-   
Net fx Rs m4691,889 24.8%   
CASH FLOW
From Operations Rs m1,1801,498 78.8%  
From Investments Rs m553201 274.9%  
From Financial Activity Rs m-1,644-1,694 97.0%  
Net Cashflow Rs m9010 870.9%  

Share Holding

Indian Promoters % 74.5 68.9 108.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 4.7 12.8%  
FIIs % 1.3 7.5 17.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 19.0 124.2%  
Shareholders   10,259 23,730 43.2%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   PROCTER & GAMBLE HEALTH  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Oct 16, 2019 02:39 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS